<DOC>
	<DOCNO>NCT00587496</DOCNO>
	<brief_summary>The purpose study determine whether oral Valtrex alone combination aspirin reduce shed herpes simplex virus DNA tear saliva volunteer evidence ocular herpes infection . The secretion virus tear saliva might make people susceptible virus infection future immune system become deficient . The study also try determine correlation shed viral DNA herpes virus antibody serum determine subject carrier special form gene blood cell , presence may suggest possibility increase susceptability herpes Alzheimer 's disease heart disease .</brief_summary>
	<brief_title>30-Day Trial Oral Valtrex Valtrex Plus Aspirin Shedding HSV DNA Tears Saliva Volunteers</brief_title>
	<detailed_description>Published study show treatment oral acyclovir reduce clinical recurrence ocular herpetic keratitis 40-50 % 8 , treatment valacyclovir , soluble prodrug acyclovir , reduce risk transmission genital herpes9 , 10 , 11 . For study , use dose valacyclovir show effective reducing risk transmission HSV-2.9 The dose 325 mg aspirin three time day choose base experience mouse laboratory animals12 . If effective well tolerate dose , future study attempt use low dos determine may effective .</detailed_description>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>either sex race age 21 year active ocular herpetic lesion ocular herpetic lesion past 30 day take systemic oral antiviral drug take antiviral drug past 30 day take aspirin NSAIDs dry eye hypersensitivity acyclovir valacyclovir hypersensitivity contraindication use aspirin bleed disorder GI ulcer kidney impairment pregnant nursing participate clinical trial past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>HSV DNA</keyword>
	<keyword>volunteer</keyword>
</DOC>